Keyphrases
Non-obese children
100%
Pharmacokinetics
100%
Midazolam
100%
Obese Adolescents
100%
Plasma Concentration
55%
Adolescents with Obesity
44%
Body Mass Index Standard Deviation Score
33%
Intravenous Administration
22%
Subtherapeutic
22%
Status Epilepticus
22%
Total Body Weight
22%
Dosing Guidelines
22%
Volume of Distribution
22%
Buccal Administration
11%
First-line Drugs
11%
Non-obese
11%
Intravenous Bolus
11%
Time-varying Data
11%
Supratherapeutic
11%
Microdosing
11%
EudraCT
11%
Pharmacokinetic Model
11%
Blood Samples
11%
Standard Deviation Score
11%
High Body Mass Index
11%
Inter-individual Variability
11%
Trial Participants
11%
Children with Obesity
11%
Therapeutic Plasma
11%
Pharmacokinetic Parameters
11%
Nonlinear Mixed Effects
11%
Time of Concentration
11%
Two-compartment Model
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetic
100%
Midazolam
100%
Volume of Distribution
22%
Epileptic State
22%
Pharmacokinetic Parameter
11%